4//SEC Filing
Mengler Christopher 4
Accession 0001209191-10-053843
CIK 0001003642other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 9:22 AM ET
Size
5.5 KB
Accession
0001209191-10-053843
Insider Transaction Report
Form 4
Mengler Christopher
President, Global Pharm. Div.
Transactions
- Sale
Common Stock
2010-11-05$19.32/sh−7,460$144,127→ 0 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price reflecting the following individual transactions: 100 shares at $19.22; 700 shares at $19.24; 200 shares at $19.25; 1,600 shares at $19.27; 100 shares at $19.28; 310 shares at $19.29; 300 shares at $19.31; 100 shares at $19.33; 100 shares at $19.34; 1,200 shares at $19.35; 600 shares at $19.36; 700 shares at $19.37; 700 shares at $19.38; and 750 shares at $19.40.
Documents
Issuer
IMPAX LABORATORIES INC
CIK 0001003642
Entity typeother
Related Parties
1- filerCIK 0001336015
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 9:22 AM ET
- Size
- 5.5 KB